Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature.
Marianna MeschiariIacopo FranconiErica BaccaVincenzo BiancoGabriella OrlandoGianluca CuomoAndrea BediniCristina MussiniPublished in: Infection (2020)
These recently developed antibiotics, C/T and CZA are promising and complementary therapy options against post-neurosurgical hard-to-treat P. aeruginosa infections. Further prospective real-life studies are required to validate these findings in this special setting.